M&A Deal Summary

ShawKwei & Partners Acquires Rauxel

On April 12, 2022, private equity firm ShawKwei & Partners acquired consumer products company Rauxel

Acquisition Highlights
  • This is ShawKwei & Partners’ 1st transaction in the Consumer Products sector.
  • This is ShawKwei & Partners’ 1st transaction in Australia.

M&A Deal Summary

Date 2022-04-12
Target Rauxel
Sector Consumer Products
Buyer(s) ShawKwei & Partners
Deal Type Buyout (LBO, MBO, MBI)

Target

Rauxel

Sydney, Australia
Rauxel is a manufacturer of beauty and healthcare products. Specializing in botanicals and natural extracts supports the global trends for sustainable, innovative, and natural beauty products. Rauxel was founded in 1986 and is based in Sydney, Australia.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

DESCRIPTION

ShawKwei & Partners is a private equity firm focused on opportunities across the greater China region. The Firm takes an active role with investments and generally targets significant ownership stakes in middle-market manufacturing and service companies. ShawKwei & Partners was established in 1999 and is headquartered in Hong Kong.


DEAL STATS #
Overall 9 of 12
Sector: Consumer Products M&A 1 of 1
Type: Buyout (LBO, MBO, MBI) M&A Deals 2 of 3
Country: Australia M&A 1 of 1
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-08 CR Asia

Singapore, Singapore

CR Asia provides specialized maintenance, plant upgrade, revamp, and engineering services in Asia and has permanent facilities in Thailand, Singapore, Malaysia, and India. The company's main objective is to become the ‘partner-of-choice’ for delivering comprehensive maintenance, plant upgrade, revamp and engineering solutions to the Oil, Gas, Refining, Petrochemical, Power and other heavy industries. It has a strong onshore and offshore capabilities, a proven track record of successful project delivery and are continually investing in new technology to improve safety and generate more value for customers. CR Asia was founded in 1991 and is based in Singapore, Singapore.

Buy $101M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-09-07 ZymeFlow

Houston, Texas, United States

ZymeFlow engages in the decontamination of hydrocarbon process equipment for entry, inspection, and maintenance including hot work. The exclusive ZymeFlow Process uses proprietary chemistry and application to achieve vessel entry in 8-12 hours. This unparalleled process prepares equipment for entry by simultaneously de-oiling while eliminating pyrophoric iron sulfide (FeS), hydrogen sulfide (H2S), benzene, and other explosive gases (LELs). ZymeFlow was founded in 2002 and is based in Houston, Texas.

Buy -